This public procurement record has 1 release in its history.

Planning

09 Jul 2026 at 08:40

Summary of the contracting process

The Betsi Cadwaladr University Health Board is in the planning stage of a procurement process for an Edoxaban Review Service aimed at reviewing prescriptions in primary care. This contract falls under the Provider Selection Regime Wales and is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. It aims to evaluate the clinical appropriateness of switching patients prescribed edoxaban to more cost-effective alternatives. The procurement is categorised under general-practitioner services, primarily located in various regions across Wales, including UKL11, UKL12, UKL13, and UKL23. Interested parties have until 22nd July 2026 to respond to this published notice, which was released on 9th July 2026, and are encouraged to send any queries or responses to Vicky Allum at the health board.

This tender represents a significant opportunity for businesses in the healthcare sector, particularly those offering pharmacy services and general practitioner capabilities, to expand their services to a wider NHS client base. Companies focusing on providing cost-effective healthcare solutions and clinical reviews would be ideally positioned to benefit from participating. The contract is designed to ensure the efficient use of healthcare resources and cost-saving through the sustainable management of pharmaceutical services, which can lead to long-term collaboration with the Betsi Cadwaladr University Health Board.

How relevant is this notice?

Notice Title

Edoxaban Review Service

Notice Description

The service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.

Lot Information

Lot 1

Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are. Part 1 - Edoxaban Patient Review Clinical review of the records of patients prescribed edoxaban. Anyone not deemed suitable for the switch must be evidenced in the records, consider using the phrase Edoxaban switch not clinically appropriate (no code) or, Edoxaban contraindicated (SNOMED CT:2949391000000118) or, Adverse reaction to edoxaban (SNOMED CT:1957181000006103). Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face. This must be documented in the notes, consider using the phrase Edoxaban switch clinically appropriate (no code) or, Edoxaban declined (SNOMED CT:1443911000000106) Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06c6ff
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/064486-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85121100 - General-practitioner services

Notice Value(s)

Tender Value
£322,860 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
9 Jul 20266 days ago
Submission Deadline
Not specified
Future Notice Date
8 Jul 2026Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
BETSI CADWALADR UNIVERSITY HEALTH BOARD
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BANGOR
Postcode
LL57 2PW
Post Town
Llandudno
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL3 North Wales
Small Region (ITL 3)
TLL32 Gwynedd
Delivery Location
TLL11 Isle of Anglesey, TLL12 Gwynedd, TLL13 Conwy and Denbighshire, TLL23 Flintshire and Wrexham

Local Authority
Gwynedd
Electoral Ward
Y Faenol
Westminster Constituency
Bangor Aberconwy

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06c6ff-2026-07-09T09:40:25+01:00",
    "date": "2026-07-09T09:40:25+01:00",
    "ocid": "ocds-h6vhtk-06c6ff",
    "description": "This is a Provider Selection Regime Wales (PSR Wales) intended approach notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The decision makers will be the Heads of Pharmacy for primary care and community services and Medical Directors (East, Central and West) ratified by the Contract Management Group. The intention is to award a contract using the most suitable provider process. Publication of notice on 9th July, 14 days to respond by 22nd July. any queries and all responses to be sent to vicky.allum@wales.nhs.uk. Any responses received after this date will not be considered. NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=166883. (WA Ref:166883)",
    "initiationType": "tender",
    "tender": {
        "id": "BCU-MSP02-Edoxaban",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Edoxaban Review Service",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "85121100",
            "description": "General-practitioner services"
        },
        "mainProcurementCategory": "services",
        "description": "The service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.",
        "value": {
            "amount": 322860,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are. Part 1 - Edoxaban Patient Review Clinical review of the records of patients prescribed edoxaban. Anyone not deemed suitable for the switch must be evidenced in the records, consider using the phrase Edoxaban switch not clinically appropriate (no code) or, Edoxaban contraindicated (SNOMED CT:2949391000000118) or, Adverse reaction to edoxaban (SNOMED CT:1957181000006103). Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face. This must be documented in the notes, consider using the phrase Edoxaban switch clinically appropriate (no code) or, Edoxaban declined (SNOMED CT:1443911000000106) Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKL11"
                    },
                    {
                        "region": "UKL12"
                    },
                    {
                        "region": "UKL13"
                    },
                    {
                        "region": "UKL23"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-07-09T00:00:00+01:00"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-183659",
            "name": "Betsi Cadwaladr University Health Board",
            "identifier": {
                "legalName": "Betsi Cadwaladr University Health Board"
            },
            "address": {
                "streetAddress": "Headquarters, Ysbyty Gwynedd, Penrhosgarnedd",
                "locality": "Bangor",
                "region": "UK",
                "postalCode": "LL57 2PW",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Victoria Allum",
                "telephone": "+44 2921501263",
                "email": "vicky.allum@wales.nhs.uk"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "https://bcuhb.nhs.wales/",
                "buyerProfile": "https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA88547",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-183659",
        "name": "Betsi Cadwaladr University Health Board"
    },
    "language": "en"
}